Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis
Autor: | Lofland, Jennifer H., Touch, Suzanne M., O'Connor, John P., Chatterton, Mary Lou, Moxey, Elizabeth D., Paddock, Lisa E., Nash, David B., Desai, Shobhana A. |
---|---|
Zdroj: | In Clinical Therapeutics 2000 22(11):1357-1369 |
Databáze: | ScienceDirect |
Externí odkaz: |